SCHEMBL25926116

SCHEMBL25926116

O=S(=O)(O)c1ccc(N=Nc2c(O)ccc(/N=N\c3ccc(S(=O)(=O)O)c4ccccc34)c2O)c2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.70
▸ CTRB1 P17538 1/20 0.68
▸ MEN1 O00255 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ THRB P10828 2/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ MPL P40238 9/20 0.57
▸ CTRC Q99895 2/20 0.57
▸ NSD2 O96028 2/20 0.54
▸ POLB P06746 1/20 0.54
▸ IDE P14735 1/20 0.54
▸ DUSP3 P51452 1/20 0.54
▸ CCR6 P51684 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ MMP14 P50281 1/20 0.53
▸ CASP6 P55212 1/20 0.53
▸ MAPK1 P28482 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15115349 1.00 CYP1A2 (0.70) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL15113020 0.92 CTRB1 (0.70) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL14580408 0.87 CYP1A2 (0.60) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL28551711 0.86 CYP1A2 (0.70) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL6763835 0.86 CTRB1 (0.73) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL5701120 0.86 CTRB1 (0.73) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL30049470 0.86 CTRB1 (0.73) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL29378273 0.85 CYP1A2 (0.68) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL2118271 0.85 CTRB1 (0.71) CYP1A2CTRB1MEN1KMT2ATHRB
SCHEMBL9577795 0.85 CTRB1 (0.71) CYP1A2CTRB1MEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 CYP1A2 762/4885CTRB1 3556/4885MEN1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback